EBS - Opiant Pharmaceuticals: A Hidden Gem With Upcoming Catalyst
Editor's note: Seeking Alpha is proud to welcome Replix Research Group LLC as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more »
Written by Nan Gao and Jiawei Zhang
Investment Thesis
Opiant Pharmaceuticals (NASDAQ: OPNT) is a micro-cap specialty pharmaceutical company, focusing on developing medicines for addictions and drug overdose. The company has limited analyst coverage (mainly David Bautz from Zacks Investment Research and Cantor Fitzgerald) and